CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-23 | Hsieh Ming Chief Executive Officer | Shares withheld for taxes | −2,625 | $31.65 | $83K | 648,555 |
| 2023-02-23 | Gao Hanlin Chief Scientific Officer | Grant or award | +2,142 | 908,254 | ||
| 2023-02-23 | Gao Hanlin Chief Scientific Officer | Grant or award | +12,156 | 920,410 | ||
| 2023-02-23 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −794 | $31.65 | $25K | 919,616 |
| 2023-02-15 | Xie Jian President and COO | Shares withheld for taxes | −1,018 | $33.99 | $35K | 424,024 |
| 2023-02-15 | KIM PAUL CFO and Treasurer | Shares withheld for taxes | −321 | $33.99 | $11K | 222,062 |
| 2023-02-15 | KIM PAUL CFO and Treasurer | Shares withheld for taxes | −1,019 | $33.99 | $35K | 221,043 |
| 2023-02-15 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −383 | $33.99 | $13K | 906,112 |
| 2023-02-03 | Xie Jian President and COO | Shares withheld for taxes | −4,408 | $36.21 | $160K | 425,042 |
| 2023-02-03 | KIM PAUL CFO and Treasurer | Shares withheld for taxes | −1,020 | $36.21 | $37K | 222,383 |
| 2023-02-01 | Xie Jian President and COO | Shares withheld for taxes | −624 | $34.75 | $22K | 429,450 |
| 2023-01-30 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −90 | $33.04 | $3K | 906,495 |
| 2023-01-03 | GROVES REGINA E Director | Grant or award | +4,000 | 4,000 | ||
| 2023-01-03 | GROVES REGINA E Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2022-12-02 | KIM PAUL CFO and Treasurer | Sale | −653 | $35.33 | $23K | 223,403 |
| 2022-11-30 | Xie Jian President and COO | Sale | −685 | $34.39 | $24K | 430,074 |
| 2022-11-16 | Xie Jian President and COO | Sale | −1,306 | $35.89 | $47K | 430,759 |
| 2022-11-16 | KIM PAUL CFO and Treasurer | Sale | −1,306 | $35.89 | $47K | 224,546 |
| 2022-11-16 | KIM PAUL CFO and Treasurer | Sale | −490 | $35.89 | $18K | 224,056 |
| 2022-11-16 | Gao Hanlin Chief Scientific Officer | Sale | −342 | $35.89 | $12K | 906,585 |
Page 17 of 23 · 453 trades